SABCS 2019: Effects of capecitabine in neo-/adjuvant chemotherapy
12.12.2019
A meta-analysis of individual patient data from 12 randomized trials including 15,457 patients. Presented as SABCS 2019.
News
24.05.2022 Ovarian Toxicity Assessment
In a paper in "The Breast" we discuss the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials.
Mehr ...22.04.2022 ESMO Breast Cancer Meeting
GBG research at ESMO Breast Cancer Meeting 2022 May 3rd to 5th in Berlin.
Mehr ...05.04.2022 2022 ESMO Breast Cancer Award for Sibylle Loibl
ESMO has announced that the 2022 ESMO Breast Cancer Award is presented to Sibylle Loibl for her exceptional contribution to clinical research in breast cancer.
Mehr ...31.01.2022 January 2022: pCR in the breast and axillary lymph nodes correlates with iDFS – results from GeparOcto trial
We are pleased to inform you that an exploratory analysis of the randomized phase III GrparOcto trial has been published in Cancer
Mehr ...
